AAAAAA

   
Results: 1-6 |
Results: 6

Authors: Sharif, S Arreaza, GA Zucker, P Mi, QS Sharif, S Arreaza, GA Zucker, P Mi, QS Sondhi, J Naidenko, OV Kronenberg, M Koezuka, Y Delovitch, TL Gombert, JM Leite-De-Moraes, M Gouarin, C Zhu, R Hameg, A Nakayama, T Taniguchi, M Lepault, F Lehuen, A Bach, JF Herbelin, A
Citation: S. Sharif et al., Activation of natural killer T cells by alpha-galactosylceramide treatmentprevents the onset and recurrence of autoimmune Type 1 diabetes, NAT MED, 7(9), 2001, pp. 1057-1062

Authors: Leite-De-Moraes, MC Hameg, A Pacilio, M Koezuka, Y Taniguchi, M Van Kaer, L Schneider, E Dy, M Herbelin, A
Citation: Mc. Leite-de-moraes et al., IL-18 enhances IL-4 production by ligand-activated NKT lymphocytes: A pro-Th2 effect of IL-18 exerted through NKT cells, J IMMUNOL, 166(2), 2001, pp. 945-951

Authors: Araujo, LM Puel, A Gouarin, C Hameg, A Mevel, JC Koezuka, Y Bach, JF Mouton, D Herbelin, A
Citation: Lm. Araujo et al., NKT lymphocyte ontogeny and function are impaired in low antibody-producerBiozzi mice: gene mapping in the interval-specific congenic strains raisedfor immunomodulatory genes, INT IMMUNOL, 12(11), 2000, pp. 1613-1622

Authors: Hameg, A Apostolou, I Leite-de-Moraes, M Gombert, JM Garcia, C Koezuka, Y Bach, JF Herbelin, A
Citation: A. Hameg et al., A subset of NKT cells that lacks the NK1.1 marker, expresses CD1d molecules, and autopresents the alpha-galactosylceramide antigen, J IMMUNOL, 165(9), 2000, pp. 4917-4926

Authors: Leite-De-Moraes, MC Hameg, A Arnould, A Machavoine, F Koezuka, Y Schneider, E Herbelin, A Dy, M
Citation: Mc. Leite-de-moraes et al., A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement, J IMMUNOL, 163(11), 1999, pp. 5871-5876

Authors: Hameg, A Gouarin, C Gombert, JM Hong, SM Van Kaer, L Bach, JF Herbelin, A
Citation: A. Hameg et al., IL-7 up-regulates IL-4 production by splenic NK1.1(+) and NK1.1(-) MHC class I-like/CD1-dependent CD4(+) T cells, J IMMUNOL, 162(12), 1999, pp. 7067-7074
Risultati: 1-6 |